Thymosin Alpha-1 Peptide Vial
A thymosin alpha-1 peptide vial contains a highly purified, synthetic 28-amino-acid peptide corresponding to the N-terminally acetylated endogenous thymic peptide. Formulated strictly for in vitro and preclinical research, it serves as a biochemical tool for studying Toll-like receptor signaling, dendritic cell maturation, and cell-mediated immune responses in controlled laboratory settings.
Quick answer
A thymosin alpha-1 peptide vial contains a highly purified, synthetic 28-amino-acid peptide corresponding to the N-terminally acetylated endogenous thymic peptide. Formulated strictly for in vitro and preclinical research, it serves as a biochemical tool for studying Toll-like receptor signaling, dendritic cell maturation, and cell-mediated immune responses in controlled laboratory settings.
Key takeaways
- [Thymosin Alpha-1](/research-peptides/thymosin-alpha-1) (Tα1) is an acidic 28-amino-acid peptide originally isolated from thymic tissue fraction 5.
- In vitro and ex vivo investigations demonstrate that [Thymosin Alpha-1](/research-peptides/thymosin-alpha-1) acts primarily through interaction with pattern recognition receptors, specifically Toll-like receptor 4 (TLR-4) and Toll-like receptor 7 (TLR-7), on dendritic cells and myeloid lineages.
- Laboratory evaluation of [Thymosin Alpha-1](/research-peptides/thymosin-alpha-1) spans several key fields of experimental biology, particularly viral replication assays, tumor microenvironment modeling, and mucosal immunity research.
- When designing preclinical study protocols involving thymic factors or tissue-repair signaling peptides, researchers often contrast [Thymosin Alpha-1](/research-peptides/thymosin-alpha-1) with other well-characterized regulatory peptides.
Molecular Structure and Biochemical Characteristics
Thymosin Alpha-1 (Tα1) is an acidic 28-amino-acid peptide originally isolated from thymic tissue fraction 5. The primary structure consists of the amino acid sequence Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH, featuring an N-terminal acetylation that confers increased enzymatic stability against aminopeptidases. With a theoretical molecular weight of approximately 3108.5 Da and an isoelectric point (pI) near 4.2, the peptide exhibits strong hydrophilic characteristics due to a high proportion of glutamic and aspartic acid residues.
When supplied as a lyophilized thymosin alpha-1 peptide vial, the material is maintained in a cake or powder format under an inert gas atmosphere. This solid-state preparation preserves the peptide backbone from hydrolytic cleavage and oxidative degradation during transit and cold storage. Synthetic production via solid-phase peptide synthesis (SPPS) ensures precise control over the primary sequence, eliminating contamination risks associated with biological extraction from animal tissue sources.
Preclinical Immunomodulatory Signaling Mechanisms
In vitro and ex vivo investigations demonstrate that Thymosin Alpha-1 acts primarily through interaction with pattern recognition receptors, specifically Toll-like receptor 4 (TLR-4) and Toll-like receptor 7 (TLR-7), on dendritic cells and myeloid lineages. Ligand binding triggers downstream signaling cascades mediated by MyD88 (Myeloid Differentiation Primary Response 88) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB).
Preclinical data published in the peptide research library indicate that activation of these signaling pathways induces the expression of major histocompatibility complex Class I (MHC-I) molecules and costimulatory markers (CD80, CD86) on antigen-presenting cells. Concurrently, assays using isolated murine splenocytes demonstrate enhanced transcription of pro-inflammatory and immunoregulatory cytokines, including Interleukin-2 (IL-2), Interleukin-12 (IL-12), and Interferon-gamma (IFN-γ). These cellular events foster T-helper 1 (Th1) phenotype differentiation and stimulate cytotoxic T-lymphocyte (CTL) activation in cell culture models.
Primary Application Areas in Cell Biology and Oncology Models
Laboratory evaluation of Thymosin Alpha-1 spans several key fields of experimental biology, particularly viral replication assays, tumor microenvironment modeling, and mucosal immunity research. In viral infection models, investigators utilize Tα1 to study signal transduction pathways that inhibit intracellular viral gene expression while upregulating endogenous interferon signaling mechanisms.
In experimental oncology assays, researchers evaluate how Tα1 modulates tumor-infiltrating lymphocytes and natural killer (NK) cell cytotoxicity. In vitro co-culture experiments indicate that exposure to Tα1 enhances NK cell expression of perforin and granzyme B, augmenting their lytic activity against target cell lines. Furthermore, researchers frequently study Tα1 alongside antimicrobial peptides such as the LL-37 antimicrobial peptide to evaluate synergistic pathogen recognition and innate immune recruitment mechanisms.
Comparative Analysis: Thymic and Immunomodulatory Research Peptides
When designing preclinical study protocols involving thymic factors or tissue-repair signaling peptides, researchers often contrast Thymosin Alpha-1 with other well-characterized regulatory peptides. While Tα1 primarily targets dendritic cell maturation and adaptive T-cell differentiation via TLR-4/7, Thymosin Beta-4 operates as a major G-actin sequestering peptide, influencing cell migration, cytoskeletal reorganization, and wound repair models.
Similarly, researchers studying soft tissue repair or gut mucosal integrity may evaluate BPC-157 or TB-500 peptide vials for their distinct angiogenic and nitric oxide modulation pathways, whereas Thymosin Alpha-1 remains focused on immune system signaling architecture. Understanding these functional distinctions enables laboratory teams to select the exact molecular tool required for their target biological pathway.
Reconstitution Protocols for Laboratory Assays
Proper reconstitution of a lyophilized thymosin alpha-1 peptide vial is required to ensure homogeny, correct nominal concentration, and structural integrity during assay execution. Before handling, the vial should be equilibrated to room temperature inside a laminar flow hood to minimize condensation on the lyophilized cake.
For standard cell culture applications, sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) is injected down the inner glass wall of the vial under gentle vacuum release. Avoid vigorous vortexing or rapid aspiration, as shearing forces can induce mechanical denaturation or aggregation. Gentle swirling or inversion allows the hydrophilic peptide cake to fully dissolve into a clear, colorless solution within seconds. Stock solutions are typically prepared at concentrations between 1 mg/mL and 5 mg/mL prior to sterile filtration and downstream dilution.
Storage, Stability, and Thermal Degradation Safeguards
Lyophilized Thymosin Alpha-1 exhibits excellent long-term chemical stability when stored in a temperature-controlled freezer at -20°C or -80°C. Under these desiccated, sub-zero conditions, the primary peptide chain resists hydrolysis and oxidative side-chain modification for extended periods.
Once reconstituted into an aqueous buffer, the peptide solution should be stored at 4°C for short-term experimentation (less than 7–10 days). For extended experimental timelines, the stock solution must be divided into single-use aliquots using polypropylene microcentrifuge tubes and stored at -20°C or colder. Repeated freeze-thaw cycles must be rigorously avoided, as ice crystal formation disrupts the solution microenvironment, promoting peptide aggregation and concentration loss.
Analytical Quality Standards and Third-Party Verification
Experimental reproducibility depends directly on the chemical purity and accurate quantification of the target peptide. PX1 Research subjects every batch of Thymosin Alpha-1 to rigorous dual-assay analytical testing in an independent, ISO 17025 accredited laboratory.
Chemical purity is established via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a baseline purity threshold exceeding 98%. Absolute identity and molecular mass verification are confirmed through Electrospray Ionization Mass Spectrometry (ESI-MS), verifying the expected monoisotopic mass peak at ~3108.5 Da without truncated synthesis side-products. Furthermore, because immune cell assays are exceptionally sensitive to lipopolysaccharides, every lot undergoes quantitative Limulus Amebocyte Lysate (LAL) testing to confirm bacterial endotoxin levels remain strictly below 0.01 EU/mg.
Bulk Sourcing and Enterprise Supply Chain Integrity
Institutional laboratories, academic research centers, and biotechnology enterprises requiring sustained inventory for longitudinal studies can access PX1 Research's bulk peptide procurement program. Every shipment originates from state-of-the-art facilities in California and Arizona, providing rapid dispatch and strict temperature-controlled packaging.
Orders placed before daily cutoffs Monday through Friday ship same-day, eliminating project delays. Each shipment includes lot-specific Certificates of Analysis (COAs) containing full RP-HPLC chromatograms, mass spectra, and endotoxin assay reports, providing complete audit-ready documentation for regulatory and institutional compliance. Researchers exploring concurrent metabolic or secretagogue signaling models can also source complementary reagents such as Ipamorelin research compounds under the same unified quality architecture.
Frequently Asked Questions
What is the chemical purity threshold for a research-grade thymosin alpha-1 peptide vial?
PX1 Research requires a minimum purity threshold of >98% for all Thymosin Alpha-1 lots, verified via analytical Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC).
How should a lyophilized thymosin alpha-1 peptide vial be stored upon arrival?
Unopened, lyophilized vials should be stored at -20°C or -80°C in a desiccated freezer environment to prevent hydrolytic degradation and ensure long-term stability.
What reconstituting diluents are suitable for in vitro assays using thymosin alpha-1?
Sterile bacteriostatic water, sterile water for injection, or sterile phosphate-buffered saline (PBS, pH 7.4) are suitable diluents depending on the requirements of your cell culture or biochemical assay.
How does thymosin alpha-1 differ structurally and functionally from thymosin beta-4?
Thymosin Alpha-1 is a 28-amino-acid peptide that modulates TLR-4/7 signaling and dendritic cell activation. Thymosin Beta-4 is a 43-amino-acid peptide that regulates actin polymerization, cell migration, and tissue repair pathways.
What analytical methods verify the molecular weight and identity of thymosin alpha-1?
Electrospray Ionization Mass Spectrometry (ESI-MS) is utilized to confirm the exact molecular mass (~3108.5 Da) and primary sequence identity, ensuring freedom from synthesis deletion sequences.
Why is endotoxin testing critical when sourcing thymosin alpha-1 peptide vials for cell culture?
Bacterial endotoxins (LPS) activate TLR-4 signaling independently, which can confound cell culture experiments measuring immune activation. PX1 Research guarantees endotoxin levels below 0.01 EU/mg via quantitative LAL assays.
What is the primary amino acid sequence and modification of thymosin alpha-1?
Thymosin Alpha-1 is an N-terminally acetylated 28-amino-acid peptide with the sequence Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH.
Can research facilities procure thymosin alpha-1 in bulk quantities?
Yes, enterprise and academic facilities can source bulk quantities with lot-matched COAs, volume pricing, and custom packaging options through the PX1 Research wholesale program.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.